Patent · US Active

Substituted pyridines and pyridazines as TYK2 inhibitors

US12103937B2 · kind B2 · utility

0Cited by

69References

21Claims

0Family size

Assignee

SUDO BIOSCIENCES LIMITED · GB

Inventors

Anjali Pandey · Fremont, US
Gregory Dietsch · Snohomish, US
Seetharaman MANOJVEER · Kanchinakote, IN
Mahesh Thakkar · Pune, IN
Athisayamani Jeyaraj Duraiswamy · Singapore, SG
Sukesh KALVA · Kanchinakote, IN

Key dates

Filing date	Feb 3, 2023
Grant date	Oct 1, 2024
Priority date	—
Expiry date	Feb 3, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/05
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are compounds of Formula (XIV) that are TYK2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of TYK2 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.